Search

everythinglearnresearchcommunity

for

Search:↓

The 308-nm Excimer laser is effective and safe for treating patchy alopecia areata in children.

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

PRP more effective than minoxidil 5% for treating alopecia areata.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Non-immune factors play a significant role in alopecia areata.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Low vitamin D levels are common in people with Alopecia Areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.